CTEV Claritev Corporation

18.28USD-3.94%Mkt Cap: 312.13M USDP/E: —

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. T…

Insiders, last 90 days5 buys
Institutional holders20 on file

Key Statistics

Company
Market Cap312.13M USD
Enterprise Value5.05B USD
Revenue (TTM)1.02B USD
Gross Profit649.05M USD
Net Income (TTM)-284.28M USD
Revenue/Share60.57 USD
Last Price18.28 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.38
PEG—
EV/EBITDA9.32
EV/Revenue4.97
P/S0.31
P/B-0.90
EPS (TTM)-16.41 USD
EPS (Forward)7.69 USD
52W Range
11.5015% of range55.50
52W High55.50 USD
52W Low11.50 USD
Profitability
Gross Margin67.23%
Oper. Margin9.52%
EBITDA Margin53.28%
Profit Margin-29.45%
ROE163.47%
ROA-5.82%
ROIC1.55%
ROCE1.95%
Growth
Revenue Growth9.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF117.32M USD
CapEx (TTM)129.60M USD
FCF Margin12.86%
FCF Yield41.90%
Net Debt4.72B USD
Net Debt/EBITDA8.71
Net Debt/FCF36.09
Balance Sheet
Debt/Equity-26.54
Current Ratio1.15
Quick Ratio0.85
Book Value/Sh-20.32 USD
Cash/Share0.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateSep 23, 2024
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)48.60 USD
Upside (mean)+165.9%
Target Range30.00 USD – 82.00 USD
30.00+165.9% to mean82.00
# Analysts5
Ownership
Shares Out.17.07M
Float6.84M
Insiders7.28%
Institutions90.87%
Short Interest
Short Ratio3.4d
Short % Float7.46%
Short % Out.4.51%
Shares Short770.03K
Short (prev mo.)978.20K
Technical
SMA 5025.35 (-27.9%)
SMA 20025.40 (-28.0%)
Beta1.05
S&P 52W Chg12.00%
Avg Vol (30d)269.11K
Avg Vol (10d)360.95K
Technical Indicators
RSI (14)34.4
MACD-0.8875
MACD Signal-0.3992
MACD Hist.-0.4883
BB Upper28.89 USD
BB Middle23.29 USD
BB Lower17.70 USD
BB Width48.04%
ATR (14)2.570 USD
Vol Ratio (20d)0.76x

About Claritev (NYSE: CTEV)

›

Claritev (NYSE: CTEV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 3,000 employees.

The shares were at 18.28 USD on 20 November 2026, down 52.1% over 52 weeks. Its 52-week range is 11.50 USD to 55.50 USD: the price is 67.1% below the high and 59.0% above the low.

Its market capitalisation is 312.13M USD.

Claritev reports return on equity of 163.5%, an operating margin of 9.5% and revenue up 9.1% year over year.

Its debt exceeds its cash by 4.72B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 48.60 USD is 165.9% above the current price. The next earnings report is expected on 23 February 2027.